Urinalysis Test Market is Increasing at a CAGR of 6.3% During Forecast to 2023

 

Market Highlights

Market Research Future (MRFR) reveals in its new report that the global urinalysis test market can expect a lucrative run at a CAGR of 6.3% during the forecast period (2014-2023).

Growth Boosters and Top Challenges

Urinalysis test is used for analyzing different substances found in the urine,including the byproducts of normal as well as abnormal metabolism, cells, cellular fragments, and bacteria. The test primarily diagnoses urinary tract infection, kidney disease, and uncontrolled diabetes. Urinalysis test is generally performed in healthcare settings including hospital and laboratories, involving the use of different types of analyzers to analyze the urine. Healthcare providers recommend a urinalysis test in case of back pain, abdominal pain, painful urination and blood in the urine.

The worldwide market for Urinalysis Test Market can expect significant growth in the near future with the growing prevalence of diseases like kidney diseases, diabetes, and urinary tract infections. The increasing adoption of point-of-care urinalysis devices could also aid in market growth. On top of that, expansion of healthcare sector in developing markets in Asia Pacific and the introduction of new products and technology are other factors projected to work in favor of the market.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/839

The market growth could face obstacles in the form of the dearth of trained professionals. But, the market growth during the review period will be relentless on account of the hike in demand for point of care testing devices and the growing prevalence of chronic diseases. Some additional factors contributing to the market growth are the availability of low-priced tests and strong demand for urine automated urine analyzers.

Key Vendors:

Dahaner (U.S.), Siemens AG (U.S.),Sysmex Corporation (Japan), ACON Laboratories, Inc. (U.S.), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland),Bio-Rad Laboratories, Inc.  (U.S.), are some of the key vendors shaping the global urinalysis test market.

Market Segmentation:

The market for urinalysis test can be segmented on the basis of product type, test type, application, and end user.

Depending on the product type, the market caters to instruments and consumables. The instruments type covers urine chemistry analyzer including automatic urine analyzers and semi-automatic urine analyzers, automated urine sediment analyzers, point-of-care devices, and strip analyzer. The consumables, on the other hand, comprise plastic consumables, test strips, and chemical agents.

With respect to the test type, the market can be considered for macroscopic urinalysis, biochemical urinalysis, and sediments/microscopic urinalysis.

Application-based segments in the market are disease diagnosis, including the diagnosis of diseases such as kidney disease, liver disease, diabetes, pregnancy tests, and others.

The end users covered by the report are hospitals, independent laboratories, and physician practices.

Regional Outlook:

MRFR provides a forecast for the worldwide urinalysis test market with respect to the regions of Europe, AsiaPacific (APAC), Middle East and Africa (MEA) and the Americas.

The Americas market’s growth is perceived to be the most effective among all the regions, backed by the surge in demand for automated urine analyzers and constant technological advancement. In addition, the growing prevalence of liver and kidney diseases will boost the market to a great extent. In the region and the global space, the United States (U.S.)is leading on account of the existence of prominent manufacturers of urine analyzers as well as consumables.

Europe has seized the second-largest share of the global urinalysis test market, which is expected to grow bigger in the years ahead. Growing prevalence of chronic diseases like diabetes, increasing government funding for research and development activities, and the availability of cost-effective treatments will benefit the market. The World Health Organization (WHO) reports that close to 60 million Europeans suffer from diabetes, with the prevalence of diabetes being relatively high in the region in the past 25 years.

Access Fyll Report Details @ https://www.marketresearchfuture.com/reports/urinalysis-test-market-839

 

The fastest-developing market is in Asia Pacific, which profits from the rising prevalence of chronic diseases such as diabetes and kidney diseases. Moreover, the evolving lifestyleand the growing demand for urine analyzers by healthcare providers will promote market growth. Diabetes is one of the significant causes of health issues among the elderly in the region, which will do wonders for the regional market in the following years.

Interestingly, the Middle East & Africa market is demonstrating a steady rise due to the surging demand for diagnostic solutions as well as point of care testing devices.

Industry News:

June 2019

Navy will be expanding its urinalysis testing program, increasing the ability to conduct drug testing for opiate drugs whenever needed. For this purpose, Navy Drug Screening Laboratories is expected to add Norfentanyland Fentanyl to the basic drug testing panel for urinalysis samples.